SeaCrest Wealth Management’s Accelerate Diagnostics AXDX Stock Holding History
Bought
Maintained
Sold
Other funds holding AXDX
GAM
BC
OIM
CC
CI
TWA
SeaCrest Wealth Management's AXDX Position: Q3 2023 in Review
SeaCrest Wealth Management sold out of Accelerate Diagnostics (AXDX) in Q3 2023, closing a stake of 2,688 shares — an estimated $21.8K sold.
SeaCrest Wealth Management first reported a position in AXDX in Q4 2017 and held it in 23 quarters. The position peaked at $643K in Q4 2017. 38 funds tracked by Wall St. Rank hold AXDX as of Q3 2023.
- SeaCrest Wealth Management reported no remaining Accelerate Diagnostics position as of Q3 2023 after selling out during the quarter.
- SeaCrest Wealth Management sold 2,688 Accelerate Diagnostics shares in Q3 2023, an estimated $21.8K.
- SeaCrest Wealth Management first reported a position in Accelerate Diagnostics in Q4 2017 and held it in 23 quarters.
- SeaCrest Wealth Management's Accelerate Diagnostics position peaked at $643K in Q4 2017.
- 38 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q3 2023.
Based on SeaCrest Wealth Management's 13F filing for Q3 2023, filed 12 Oct 2023.